The Attention Economy Just Got a $56 Billion Price Tag — And It Changes How We Should Think About Vision Training

Ryan Cohen wants to buy eBay. For $56 billion. His stated reason: to build a "legit competitor to Amazon."

Strip away the corporate drama, and you'll find a simpler thesis underneath. The companies that dominate the next decade won't be the ones with the best supply chains. They'll be the ones that command attention — where people look, click, and linger.

This is the attention economy in its purest form. And it has implications far beyond e-commerce.

From Marketplace to Mindshare

Cohen's move — whether it succeeds or not — crystallizes something we all intuitively know: attention is the most valuable resource in the modern economy. Amazon didn't just build warehouses. It became the reflexive starting point for nearly every product search. That habit, multiplied across hundreds of millions of people, is worth more than any physical asset.

But here's the twist: the same forces reshaping retail are quietly reshaping healthcare, education, and rehabilitation. The winners in those fields won't just have the best clinical evidence. They'll have the best engagement.

The Engagement Problem in Vision Therapy

Take amblyopia. It's one of the most common vision disorders, affecting roughly 1 in 30 people. The standard treatment — patching the dominant eye — has been around for centuries. It works, in theory. In practice, it fails constantly.

Why? Because patching is boring, socially stigmatizing, and miserable to sustain — especially for children. Compliance rates are dismal. And when people don't do the treatment, the treatment doesn't work.

This isn't a medical failure. It's an attention failure.

Enter Amblyotube: Training Vision Through Entertainment

Amblyotube, developed by Seven Sports for Meta Quest, is built on a radically simple insight: if you want someone to train their vision, meet them where their attention already is.

The app shows each eye a different visual experience while the user watches YouTube-style content. The amblyopic (weaker) eye gets a more demanding feed that requires it to work harder. The dominant eye gets a controlled, reduced-contrast version. The brain — unconsciously — integrates both, strengthening binocular coordination over time.

From the user's perspective, nothing clinical is happening. They're just watching videos they enjoy.

Under the hood, it's dichoptic training — a well-researched approach to amblyopia treatment that presents different images to each eye to encourage binocular combination. Studies suggest it can improve visual acuity and stereoacuity in both children and adults, often with better compliance than patching.

What Amblyotube adds is the engagement layer. The same layer that makes Amazon, TikTok, and YouTube unstoppable. Content people actually want.

Why This Moment Matters

GameStop bidding $56 billion for eBay is a story about attention. But it's also a signal. The battleground of the next decade is the space between someone's ears — and the technologies that can reach into that space and deliver value without demanding sacrifice will win.

VR is uniquely positioned here. It can control what each eye sees independently — something no flat screen can do. It can immerse. It can entertain. And it can, quietly, in the background, train the brain to see better.

Amblyotube isn't the only answer to the engagement problem in healthcare. But it's a clear example of what happens when you stop fighting for attention and start building around it.

Try It

Amblyotube is available now on Meta Quest. If you or someone you care about is working through lazy eye or visual coordination challenges, it offers a different approach — one that doesn't ask you to endure treatment, just to enjoy your screen time with purpose.

Explore Amblyotube on Meta Quest

---

Disclaimer: Amblyotube is recreational and educational software designed for visual coordination and attention exercises. It is not a medical device. Consult a vision care professional for diagnosis and treatment of amblyopia.